Grifols SA GRFS:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 4:00 PM EDT
17.97UNCH (UNCH)
Volume
736
Close
17.97quote price arrow up+0.07 (+0.39%)
Volume
267,060
52 week range
14.81 - 20.98

...

Loading . . .
  • Open17.83
  • Day High18.15
  • Day Low17.68
  • Prev Close17.90
  • 52 Week High20.98
  • 52 Week High Date05/21/20
  • 52 Week Low14.81
  • 52 Week Low Date03/10/21

Key Stats

  • Market Cap12,082.18M
  • Shares Out684.54M
  • 10 Day Average Volume0.54M
  • Dividend0.42
  • Dividend Yield2.36%
  • Beta0.46
  • YTD % Change-2.55

KEY STATS

  • Open17.83
  • Day High18.15
  • Day Low17.68
  • Prev Close17.90
  • 52 Week High20.98
  • 52 Week High Date05/21/20
  • 52 Week Low14.81
  • 52 Week Low Date03/10/21
  • Market Cap12,082.18M
  • Shares Out684.54M
  • 10 Day Average Volume0.54M
  • Dividend0.42
  • Dividend Yield2.36%
  • Beta0.46
  • YTD % Change-2.55

RATIOS/PROFITABILITY

  • EPS (TTM)-
  • P/E (TTM)-
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)-
  • ROE (MRQ)-
  • Revenue (MRQ)-
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date08/06/2021
  • Ex Div Date10/30/2020
  • Div Amount0.2014
  • Split Date-
  • Split Factor-

Profile

MORE
Grifols SA is a Spain-based global specialty pharmaceutical company developing, manufacturing and distributing a broad range of biological medicines based on plasma derived proteins. It organizes its business into five divisions: Bioscience, Diagnostic, Hospital, Bio Supplies and Others. Bioscience includes manufacturing activities of plasma derivatives for therapeutic use and the sale and distribution of end products. Diagnostic focuses on researching, developing...
Victor Grifols Roura
Non-Executive Chairman
Alfredo Arroyo Guerra
Chief Financial Officer
Javier Sueiras Gil
Chief Technology Officer
Address
C/ Jesus y Maria, 6
Barcelona, BAR
08022
Spain

Top Peers

SYMBOLLASTCHG%CHG
SYNH
Syneos Health Inc
81.34+0.01+0.01%
PRAH
PRA Health Sciences Inc
170.31+0.93+0.55%
CRL
Charles River Laboratories International Inc
336.84-8.37-2.42%
INCY
Incyte Corp
82.31+1.03+1.27%
NVZMY
Novozymes A/S
72.21-0.15-0.21%